American Journal of Ophthalmology
Volume 141, Issue 1 , Pages 201-203, January 2006

Evaluation of Plasma Homocysteine and Risk of Age-Related Macular Degeneration

  • Johanna M. Seddon, MD, ScM

      Affiliations

    • Epidemiology Unit, Massachusetts Eye and Ear Infirmary, the Department of Ophthalmology, Harvard Medical School and the Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
    • The EMMES Corporation, Rockville, Maryland
    • Devers Eye Institute, Portland, Oregon
    • Corresponding Author InformationInquiries to Johanna M. Seddon, MD, ScM, Epidemiology Unit, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114
    • ,
  • Gary Gensler, MS

      Affiliations

    • The EMMES Corporation, Rockville, Maryland
    • ,
  • Michael L. Klein, MD

      Affiliations

    • Devers Eye Institute, Portland, Oregon
    • ,
  • Roy C. Milton, PhD

      Affiliations

    • The EMMES Corporation, Rockville, Maryland

Accepted 25 July 2005. published online 21 October 2005.

Purpose

To assess the relationship between plasma levels of homocysteine and age-related macular degeneration (AMD).

Design

Cross-sectional, case-control study.

Methods

Fasting plasma homocysteine levels were measured at two centers in 934 individuals who were participating in an ancillary study of the Age-Related Eye Disease Study. There were 547 cases and 387 control subjects, who were determined by fundus photography. Conditional logistic regression analyses were conducted to assess the association of homocysteine with AMD.

Results

Median values of homocysteine were higher among advanced AMD cases (9.51 mmol/l) compared with persons with no AMD (8.81 mmol/l; P = .01). Values of >12 mmol/l vs ≤12 mmol/l were also associated with an increased risk of AMD (P = .023), when controlled for other covariates.

Conclusion

Results are consistent with a possible small, independent association between higher homocysteine levels and AMD. Homocysteine may be a modifiable risk factor for AMD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of Interest Statement: Massachusetts Eye and Ear Infirmary has pending US and international patent applications that include related subject matter. In the event that Massachusetts Eye and Ear Infirmary receives any proceeds that are related to the subject matter described in this article, all proceeds will be distributed per the institutional policies governing royalties and intellectual property.Supported by National Institutes of Health grants RO1EY13982, NO1EY02117, NO1EY02126; the Massachusetts Eye and Ear Infirmary Epidemiology Unit Research Fund; and the Good Samaritan Foundation, Portland, Oregon.

PII: S0002-9394(05)00861-5

doi:10.1016/j.ajo.2005.07.059

American Journal of Ophthalmology
Volume 141, Issue 1 , Pages 201-203, January 2006

Article Tools

* Image Usage & Resolution